Nightingale Health Oyj Statistics

Total Valuation

HEL:HEALTH has a market cap or net worth of EUR 86.80 million. The enterprise value is 48.88 million.

Market Cap	86.80M
Enterprise Value	48.88M

Important Dates

The last earnings date was Thursday, March 5, 2026.

Earnings Date	Mar 5, 2026
Ex-Dividend Date	n/a

Share Statistics

HEL:HEALTH has 60.28 million shares outstanding.

Current Share Class	40.54M
Shares Outstanding	60.28M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-1.88%
Owned by Insiders (%)	30.03%
Owned by Institutions (%)	4.70%
Float	34.63M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	18.11
PB Ratio	1.50
P/TBV Ratio	1.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.56
EV / Sales	10.20
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.65

Financial Position

The company has a current ratio of 8.53, with a Debt / Equity ratio of 0.08.

Current Ratio	8.53
Quick Ratio	8.19
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	-0.36
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -28.54% and return on invested capital (ROIC) is -16.96%.

Return on Equity (ROE)	-28.54%
Return on Assets (ROA)	-16.07%
Return on Invested Capital (ROIC)	-16.96%
Return on Capital Employed (ROCE)	-30.92%
Weighted Average Cost of Capital (WACC)	5.80%
Revenue Per Employee	47,940
Profits Per Employee	-190,730
Employee Count	100
Asset Turnover	0.06
Inventory Turnover	0.99

Taxes

In the past 12 months, HEL:HEALTH has paid 45,000 in taxes.

Income Tax	45,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -43.80% in the last 52 weeks. The beta is 0.34, so HEL:HEALTH's price volatility has been lower than the market average.

Beta (5Y)	0.34
52-Week Price Change	-43.80%
50-Day Moving Average	1.79
200-Day Moving Average	2.27
Relative Strength Index (RSI)	35.26
Average Volume (20 Days)	54,496

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HEL:HEALTH had revenue of EUR 4.79 million and -19.07 million in losses.

Revenue	4.79M
Gross Profit	3.23M
Operating Income	-19.03M
Pretax Income	-19.03M
Net Income	-19.07M
EBITDA	-15.12M
EBIT	-19.03M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 42.81 million in cash and 4.89 million in debt, giving a net cash position of 37.93 million or 0.63 per share.

Cash & Cash Equivalents	42.81M
Total Debt	4.89M
Net Cash	37.93M
Net Cash Per Share	0.63
Equity (Book Value)	57.99M
Book Value Per Share	n/a
Working Capital	41.41M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.92 million and capital expenditures -2.48 million, giving a free cash flow of -13.40 million.

Operating Cash Flow	-10.92M
Capital Expenditures	-2.48M
Free Cash Flow	-13.40M
FCF Per Share	-0.22

Full Cash Flow Statement

Margins

Gross Margin	67.36%
Operating Margin	-396.91%
Pretax Margin	-396.91%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

HEL:HEALTH does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-21.97%
FCF Yield	-15.43%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2